Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATOS | TMO | ISRG | EW | IDXX |
| Company | Atossa Therapeutics Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Idexx Laboratories |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 1.7100 | 574.23 | 381.79 | 85.31 | 488.28 |
| High | 1.7400 | 579.07 | 387.33 | 87.79 | 505.07 |
| Low | 1.6129 | 572.50 | 380.69 | 85.01 | 488.28 |
| Last | 1.6900 | 577.93 | 385.45 | 87.42 | 500.82 |
| Change | +0.0100 | +4.29 | +5.08 | +2.33 | +13.75 |
| % Change | +0.60% | +0.75% | +1.34% | +2.74% | +2.82% |
| Volume | 1,182,800 | 1,513,300 | 882,100 | 3,421,900 | 546,500 |
| 20-Day Average Volume | 1,532,765 | 1,514,515 | 1,440,800 | 2,932,020 | 524,845 |
| Previous Close | 1.6800 | 573.64 | 380.37 | 85.09 | 487.07 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5525 | 565.96 | 376.82 | 86.78 | 486.91 |
| 20-Day Raw Stochastic | 76.27% | 84.98% | 75.68% | 47.63% | 82.82% |
| 20-Day Relative Strength | 56.46% | 54.28% | 53.11% | 49.07% | 48.89% |
| Weighted Alpha | +110.75 | +13.16 | +29.08 | +4.76 | +1.76 |
| Today's Opinion | 88% Buy | 72% Buy | 72% Buy | 56% Buy | 40% Sell |
| Previous Opinion | 88% Buy | 56% Buy | 56% Buy | 40% Buy | 40% Sell |
| Last Month's Opinion | 100% Buy | 88% Buy | 80% Buy | 80% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.18% since 05/02/24 | +1.17% since 05/02/24 | +2.07% since 05/02/24 | +2.77% since 05/02/24 | +5.25% since 05/02/24 |
| Low | 1.5300 on 05/03/24 | 565.34 on 05/07/24 | 378.87 on 05/03/24 | 84.81 on 05/06/24 | 473.80 on 05/06/24 |
| High | 1.8100 on 05/08/24 | 579.84 on 05/03/24 | 389.78 on 05/07/24 | 87.79 on 05/09/24 | 505.07 on 05/09/24 |
| 1-Month | |||||
| %Chg | -8.15% since 04/09/24 | -1.91% since 04/09/24 | -1.41% since 04/09/24 | -6.05% since 04/09/24 | -3.65% since 04/09/24 |
| Low | 1.2400 on 04/18/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 83.50 on 05/01/24 | 462.00 on 05/01/24 |
| High | 1.8400 on 04/11/24 | 586.46 on 04/24/24 | 392.80 on 04/11/24 | 92.99 on 04/11/24 | 512.72 on 04/10/24 |
| 3-Month | |||||
| %Chg | +80.61% since 02/09/24 | +4.94% since 02/09/24 | -0.71% since 02/09/24 | +2.83% since 02/09/24 | -12.48% since 02/09/24 |
| Low | 0.9500 on 02/13/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 83.50 on 05/01/24 | 462.00 on 05/01/24 |
| High | 2.3100 on 04/05/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 583.39 on 03/01/24 |
| 6-Month | |||||
| %Chg | +154.90% since 11/09/23 | +30.09% since 11/09/23 | +41.50% since 11/09/23 | +35.22% since 11/09/23 | +19.60% since 11/09/23 |
| Low | 0.6200 on 11/13/23 | 437.26 on 11/10/23 | 269.49 on 11/10/23 | 63.88 on 11/10/23 | 417.93 on 11/10/23 |
| High | 2.3100 on 04/05/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 583.39 on 03/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 211,764 | 220,605,120 | 136,719,120 | 52,679,288 | 41,361,216 |
| Shares Outstanding, K | 125,304 | 381,716 | 354,700 | 602,600 | 82,587 |
| Annual Sales | 0 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,660,950,000 |
| Annual Net Income | -30,090,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 845,040,000 |
| Last Quarter Sales | 0 | 10,345,000,000 | 1,890,600,000 | 1,598,200,000 | 964,100,000 |
| Last Quarter Net Income | -7,750,000 | 1,327,000,000 | 544,900,000 | 351,900,000 | 235,580,000 |
| 60-Month Beta | 1.27 | 0.80 | 1.39 | 1.10 | 1.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 04/01/24 | 5.11 on 04/24/24 | 1.50 on 04/18/24 | 0.66 on 04/25/24 | 2.81 on 05/01/24 |
| Latest Earnings Date | 05/20/24 | 04/24/24 | 04/18/24 | 04/25/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.53 | 81.28 | 33.37 | 47.15 |